Technological innovation in genetic testing has brought new possibilities in medicine and personal health management. However, as genetic testing becomes more widespread, safety and ethical issues have emerged, and regulations and guidelines are being formulated in each country. This article provides a comprehensive explanation of the international regulatory situation regarding genetic testing, ensuring safety, and ethical issues.
1. Overview of genetic testing and its prevalence
Genetic testing is a technology that analyzes an individual’s DNA to reveal disease risks and genetic characteristics. This is expected to promote personalized medicine and develop preventive medicine. In recent years, direct-to-consumer (DTC) genetic testing has emerged, allowing individuals to obtain their own genetic information without going through a medical institution. However, concerns have been raised about the reliability of these services and the interpretation of the results.
2. International Regulations and Guidelines
Regulations regarding genetic testing vary by country and region, but they all share the same emphasis on the following points:
2.1 United States
In the United States, the Genetic Information Nondiscrimination Act (GINA) was enacted in 2008 to prohibit discrimination based on genetic information. In addition, the Food and Drug Administration (FDA) oversees the safety and effectiveness of genetic testing kits to protect consumers.
2.2 European Union (EU)
In the EU, the In Vitro Diagnostic Medical Devices Regulation (IVDR) will come into force in 2022 and imposes strict requirements on the safety and performance of in vitro diagnostic medical devices, including genetic tests, while the General Data Protection Regulation (GDPR) strengthens the protection of individuals’ genetic information.
2.3 Japan
In Japan, there are no clear laws and regulations regarding genetic testing, but the Japan Society of Human Genetics and the Japanese Medical Association have formulated guidelines to promote appropriate implementation. For example, the “Guidelines for Genetic Testing and Diagnosis in Medical Care” emphasize the importance of proper implementation of testing and genetic counseling.
3. Ensuring safety
The following factors are important to ensure the safety of genetic testing:
3.1 Reliability of the test
Quality control of the testing laboratory is essential to ensure accuracy and reproducibility of test results. International Organization for Standardization (ISO) accreditation and/or participation in external quality control programs are recommended.
3.2 Data Protection
Since genetic information is deeply related to individual privacy, appropriate data protection is required. In addition to legal regulations such as GDPR, data protection laws are being established in each country.
4. Ethical Issues
As genetic testing becomes more widespread, the following ethical issues have arisen:
4.1 Genetic discrimination
There are concerns about the possibility of discrimination based on genetic information (genotype discrimination). Cases have been reported in which people have been disadvantaged in applying for insurance or employment due to their genetic risk.
citeturn0search4
4.2 Informed consent
It is important that subjects fully understand the purpose of the test, the interpretation of the results, and the potential risks before consenting. Appropriate genetic counseling should be provided. citeturn0search3
4.3 Impact on families
Because genetic information may affect blood relatives, ethical considerations must be taken into account regarding sharing and informing results.
6. Commercialization of genetic testing and consumer challenges
In recent years, the market for direct-to-consumer (DTC) genetic testing has grown rapidly, increasing the opportunities for individuals to obtain genetic information without going through a medical institution. Companies that provide genetic testing offer a wide range of services, including ancestry analysis, health risk assessment, and diet and exercise optimization. However, the scientific basis of these services and the interpretation of their results require careful consideration.
6.1 The issue of scientific evidence
The results of DTC genetic testing are not universally applicable to everyone. Information on specific disease risks and predispositions is influenced by many environmental factors and lifestyle habits, making it difficult to draw definitive conclusions from genetic information alone. For example, even if a certain gene mutation is said to increase the risk of a certain disease, it does not necessarily lead to the onset of the disease, which can be misleading.
In addition, because some companies use their own databases and analysis algorithms, the same individual may get different results when tested by different companies, causing confusion for consumers about which information to trust.
6.2 Risks of self-diagnosis of genetic test results
Among users of DTC genetic testing, there are an increasing number of cases where people are overconfident in the test results and attempt to diagnose themselves without a doctor’s diagnosis. For example, there have been reported cases where people who received a result indicating a “high risk of cancer” became overly anxious and underwent unnecessary medical tests, or conversely, cases where people who were judged to be at “low risk” neglected their health management.
The importance of genetic counseling is increasing due to an increase in services that provide genetic information without the involvement of medical institutions. Without proper interpretation and advice from experts, there is a risk that the results of genetic tests will be misunderstood, so there is a need to strengthen consumer education.
6.3 Commercial Use of Genetic Data and Privacy Risks
Many DTC genetic testing companies make money by providing consumers’ genetic data to third parties. While they partner with pharmaceutical companies and research institutes to advance new drug development and genetic research, they are also required to properly manage personal information.
In recent years, there have been cases of consumers having their genetic data sold without their consent, and problems with data management becoming unclear when companies go bankrupt. In particular, because genetic information cannot be changed, there is a risk that once it is leaked, it may become irreversible.
In response to these issues, laws such as the European GDPR and the California Consumer Privacy Act (CCPA) are moving to restrict the use of genetic data and strengthen the protection of consumer rights. However, companies offering DTC genetic testing do not necessarily comply with these regulations, so consumers themselves need to be careful when choosing a service.
7. Interactions between gene editing technology and regulations
Another important topic related to genetic testing is the relationship between advances in genome editing technology and regulations. Technologies such as CRISPR-Cas9 make it possible to modify specific genes, and are being applied in many fields, including the treatment of genetic diseases and crop breeding.
7.1 Regulation of human gene editing
In 2018, a Chinese researcher gave birth to genetically altered twin babies using genome editing technology, sparking a global ethical debate. In response to this incident, many countries have strengthened their efforts to strictly regulate the genetic modification of reproductive cells (sperm and eggs).
Currently, regulations regarding human gene editing read as follows:
USA : FDA bans human germline genome editing
EU : Germline gene editing restricted under strict ethical regulations
Japan : Germline editing is banned, but research into somatic cell editing (gene editing for the purpose of treating disease) is ongoing
7.2 Gene editing and ethical issues in sports
Gene editing technology could also have an impact on the world of sports. If a technique known as “gene doping” becomes widespread, it could be possible to modify specific genes that increase muscle mass or improve endurance, thereby unfairly improving athletic performance.
The World Anti-Doping Agency (WADA) has added gene editing to its prohibited list of doping practices and is implementing strict monitoring measures. However, advances in gene editing technology mean that there is a possibility that cases that are difficult to detect may increase, and further strengthening of regulations is required.
8. Genetic testing and social acceptance
Social acceptance of genetic testing and gene editing technology varies by country and culture. For example, in the West, there is a strong tendency to respect the freedom of individual choice, whereas in Japan and other Asian countries, the impact on the family and society as a whole is often taken into consideration.
The decision to undergo genetic testing is influenced not only by scientific evidence, but also by ethical values and cultural background. Therefore, it is important to deepen international discussion and to improve education and information provision for consumers
9. Genetic testing and the insurance industry
The spread of genetic testing is also having a major impact on the insurance industry. If it is discovered that certain genetic mutations increase the risk of disease, this could affect the underwriting standards for life and medical insurance. For this reason, countries are beginning to develop regulations regarding the use of genetic information in the insurance industry.
9.1 Insurance and restrictions on the use of genetic information
Some countries have enacted legislation to ensure that genetic information does not affect insurance contracts.
United States : The Genetic Information Nondiscrimination Act (GINA), enacted in 2008, prohibits health insurance companies from using genetic information to determine premiums, but does not apply to life or disability insurance.
UK : An agreement between the government and the insurance industry has been reached which means that genetic test results will not be used as a basis for deciding on insurance policies, with the exception of large life insurance policies (over around £500,000)
Australia : From 2021, self-regulation has been introduced for life insurance policies below a certain amount that prohibits contract restrictions based on genetic test results.
On the other hand, in Japan, there are no clear legal regulations, and each insurance company has a different approach. There is a need to create rules to ensure that genetic information is treated fairly.
9.2 Premium discrimination and ethical issues
If genetic tests could predict future disease risk, insurance companies could raise premiums or refuse to insure those at high risk, which could encourage discrimination against people with certain genetic characteristics.
It is also possible that consumers may intentionally not disclose the results of genetic testing and only learn of the risks after taking out insurance. This could lead to information asymmetry between insurance companies and policyholders, making it difficult to conclude fair contracts.
To solve this problem, some countries are discussing the introduction of “restrictions on the obligation to disclose genetic test results” and “contract options that do not use genetic information.”
10. Genetic testing and criminal investigation
In the field of forensic science, DNA identification technology is increasingly becoming the decisive evidence in criminal investigations. In recent years, the use of genetic data in criminal investigations has progressed, and cases that could not be solved using traditional investigative methods are being solved one after another.
10.1 Use of DNA (Genetic Genealogy) for Tracing Family Trees
In recent years, the use of DNA tracing in criminal investigations has been attracting attention. This is a method of identifying suspects by comparing their DNA with that of individuals registered in a genetic database and using blood ties as clues.
In 2018, the cold case of the “Golden State Killer” was solved in the United States using this technology. Although the killer’s own DNA was not registered, the DNA data of his relatives provided clues and ultimately led to the identification of the suspect.
This success has prompted the FBI and other law enforcement agencies to increasingly use genetic databases to solve cold cases, but it has also raised privacy concerns and sparked ethical debate about the use of genetic information.
10.2 DNA Databases and Privacy
The use of DNA databases by law enforcement agencies requires proper regulation and oversight.
United States : Some states have clear guidelines for the use of DNA databases, but states vary.
EU : GDPR strictly regulates the handling of genetic information, and strict requirements must be met before law enforcement agencies can use genetic data.
In Japan, police DNA databases are expanding, but specific rules regarding privacy protection have not yet been established, and future legal developments are required
11. International sharing of genetic data and its impact on research
The sharing of large-scale genetic information is essential for the advancement of genetic research. Research institutes and companies from around the world are working together to integrate genetic data, helping to clarify the mechanisms of new diseases and develop treatments.
11.1 International data sharing projects
The Human Genome Project: Launched in 1990, the entire human genome sequence was deciphered in 2003.
The 100,000 Genomes Project (UK): A project that aims to develop personalized medicine by analyzing the genomes of 100,000 people.
The Global Alliance for Genomics and Health (GA4GH) : Research institutions from around the world work together to develop guidelines for sharing genetic information and its ethical handling.
These efforts are accelerating the identification of genes that increase disease risk and the realization of personalized medicine.
11.2 Data sharing challenges
While international sharing of genetic information promotes research progress, it also poses the following challenges:
Ensuring privacy : As the data contains personally identifiable information, it must be appropriately anonymized and protected.
Data standardization : Uniform standards are required because research institutions in each country manage data in different formats.
Issues with commercial use : There is a risk that companies will build their own databases and monopolise the profits.
In order to resolve these issues, international rule-making is underway.
While the development of genetic testing brings many possibilities, it also brings with it issues of safety, ethics, and privacy. How to balance technological innovation and regulation will be a key challenge in the future.
12. The need for genetic testing and education
As genetic testing becomes more widespread, it is becoming increasingly important to educate the general public and medical professionals so that they can correctly understand genetic information. Misinterpreting the results of genetic testing can lead to anxiety and the risk of making incorrect decisions. In particular, as the number of users of DTC genetic testing increases, knowledge on how to properly utilize test results is essential.
12.1 Genetics education for the general public
When the general public uses genetic testing, they may have the following misconceptions:
“Genetic testing is 100% accurate” : In reality, genes alone cannot determine your future, as environmental factors and lifestyle habits have a significant impact on health risks.
“High genetic risk = you’ll definitely get the disease” : Many diseases are caused by multiple genes, and risk is not determined by a single gene mutation alone.
“Genetic test results are absolute” : If you take genetic tests at different companies, the results may vary.
In order to eliminate these misunderstandings, educational institutions and public organizations are being called upon to develop genetic education programs. For example, it is important to teach the basics of genetics in school education and promote correct understanding of genetic information. It is also necessary for the government and medical institutions to conduct awareness-raising activities for the general public and provide reliable information.
12.2 Education for Healthcare Professionals
Medical professionals are also required to have the ability to properly interpret genetic test results and explain them to patients. In particular, the importance of genetic counseling is increasing, so doctors, nurses, and clinical laboratory technicians need to deepen their knowledge when handling genetic information.
In Europe and the United States, the profession of genetic counselor is widespread, and their role is to explain the results of genetic tests to patients and provide appropriate advice. In Japan, too, efforts are being made to train genetic counselors, but they are not yet widespread enough.
In addition, it is important to expand continuing education programs for healthcare professionals, providing them with opportunities to learn about the latest genetic technologies and ethical issues.
13. Genetic testing and personalized medicine
Genetic testing also contributes to the realization of “precision medicine,” which selects the most appropriate medicine for each patient. Because differences in genes affect how drugs work and the risk of side effects vary, it becomes possible to select the most appropriate treatment for each patient.
13.1 Pharmacogenomics
Through the analysis of genes involved in drug metabolism, methods are being developed to determine the optimal type and dosage of drugs for each patient. For example, there are the following cases:
Warfarin (anticoagulant) : The appropriate dosage can be determined by analyzing mutations in the CYP2C9 and VKORC1 genes, which are involved in the metabolism of warfarin.
Anticancer drugs : Genetic mutations that affect the metabolism of some anticancer drugs (e.g., tamoxifen) can be tested to create effective drug regimens.
Psychiatric medications : Predict the effectiveness and risk of side effects of antidepressants and antipsychotics to provide treatment tailored to the patient.
Such techniques could allow for personalized treatment, maximizing therapeutic benefit while minimizing side effects.
13.2 Challenges and future prospects
The following challenges exist in the widespread adoption of personalized medicine.
Cost issues : Treatments based on genetic testing are often expensive, and insurance coverage is limited.
Accumulating data and improving analytical accuracy : More patient data is needed to establish treatments based on genetic information.
Improving the knowledge of medical professionals : It is important that doctors and pharmacists are able to correctly interpret the results of genetic tests and explain them appropriately to patients.
As technology advances, it is expected that personalized medicine using genetic information will become more common in the future.
14. Genetic Technology and Social Acceptance
The development of genetic testing and genome editing technology is not only a scientific advancement, but also has an impact on the values and ethics of society as a whole.
14.1 Religious and Cultural Differences
Acceptance of genetic technology varies by country and culture. For example, some religions take a negative stance against gene editing. In particular, there are many opposing views on genome editing of reproductive cells, based on the ethical view that “humans should not manipulate life given by God.”
In addition, while Europe has a strong cautious stance toward gene editing technology, the United States and China are relatively proactive in their research. Interest in gene editing technology is also growing in Japan, but a social consensus needs to be formed.
14.2 Ethical dilemmas
While genetic testing can identify disease risks at an early stage, it also carries the risk of forcing people to know about a “future they don’t want to know about. If it turns out that someone has a specific genetic mutation, many ethical issues remain, such as whether that information should be shared with family members and whether gene editing should be used to select the characteristics of future children.
In addition, society is not able to keep up with the rapid pace of technological advancement. There is a need to have appropriate discussions and achieve harmony between science, technology and society.
As such, the development of genetic technology has the potential to greatly change our lives, but its use requires careful judgment and social consensus. How to balance technological innovation and regulations in the future will be a global challenge.
Summary
The development of genetic testing is affecting many areas, including healthcare, insurance, criminal investigations, and personalized medicine. However, privacy protection, ethical issues, and the risk of misuse of genetic information have also been raised. While regulations on the handling of genetic information are being established in each country, consumer education and improved knowledge among medical professionals are essential. In the future, appropriate rules will need to be created while balancing technological innovation and social consensus. Whether the development of genetic technology will be beneficial for humanity depends on our choices.
